enGene Therapeutics Inc. (ENGNW) Warrants
Each ENGNW warrant gives the holder the right to buy 1 share of enGene Therapeutics Inc. at $11.50 per share, until October 31, 2028. The stock last closed at $1.76, below the strike, so the warrant is out of the money. enGene Therapeutics Inc. has a market value of about $117.95M. There are 8.55M listed warrants; exercising all of them would add 12.8% to the 67.02M shares outstanding. The company can call the warrants if the stock trades at or above $18.00.
enGene Therapeutics Inc. reports its business to the SEC as “Biological Products, (No Diagnostic Substances)”, with its head office in Saint-Laurent; it is incorporated in Canada (Federal Level). Its latest SEC filing was on November 12, 2026: current report (results; investor update; other events), form 8-K. The warrant closed at $0.1613 on November 19, 2026, down 93% from $2.21 on November 18, 2025. ENGN trades at 15% of the strike; it would have to rise about 7-fold to reach it.
Thinly traded: ENGNW traded about $360 a day over the last 30 days, and on only 13 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.
Key terms
- Strike per share
- $11.50
- Shares per warrant
- 1
- Cash to exercise one warrant
- $11.50
- Expiry
- 2028-10-31
- Redemption trigger
- $18.00
- Cashless exercise
- no
- Break-even stock price
- $11.66
Checked against the issuer's SEC filing of 2025. The terms were first set out in its S-1/A of 2024-02-27.
Redemption risk Low
ENGN closed at or above $18.00 on 0 of the last 30 trading days. The company can call the warrants once it reaches 20, so 20 more days above the trigger would be enough.
- Trigger price
- $18.00
- Last close
- $1.76 (10% of trigger)
- Days at or above, last 30
- 0 (needs 20)
The usual rule: 20 closes at or above the trigger within 30 trading days, then 30 days' notice. Some companies use a different test; check the warrant agreement. Counted from daily closes up to 2026-11-20. Follow ENGNW to get an email when it gets close.
Exercise calculator
Each warrant buys 1 share at $11.50. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- enGene Therapeutics Inc.
- Underlying stock
- ENGN
- Share price
- $1.76
- Market cap
- $117.95M
- Shares outstanding
- 67.02M
- 12-month range
- $1.44 – $12.17
- 12-month change
- -74%
- Value of all listed warrants
- $1.38M (1.2% of market cap)
- Industry
- Biological Products, (No Diagnostic Substances)
- Head office
- Saint-Laurent
- Incorporated in
- Canada (Federal Level)
Market cap is the last share price times shares outstanding (as of 2026-09-02). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
The stock is at 15% of the strike; this far from it the answer is mostly a guess about volatility.
- Last price
- $0.1613
- Low and high estimate
- $0.0040 – $0.2134
- Stock volatility, measured
- 183% (three days make up most of it)
- Volatility we use
- 50% · 80% · 100%
- Volatility the price implies
- 90%
- Redemption trigger
- $18.00
- Effect of dilution
- −5.2%
- Method
- day-by-day tree with the redemption trigger
The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.
Dilution
- Shares outstanding
- 67.02M
- Listed warrants
- 8.55M
- Dilution if all exercised
- 12.8%
Warrant count from the data the company files with the SEC.
Filings
- 8-KCurrent report: results; investor update; other events
- 10-QQuarterly report
- 8-KCurrent report: results
- 8-KCurrent report: other events
- 8-KCurrent report: investor update
- 8-KCurrent report: directors or officers changed; investor update
- 8-K/ACurrent report (amended): restructuring costs; directors or officers changed
- 10-QQuarterly report
- 8-KCurrent report: results; restructuring costs; directors or officers changed; investor update; other events
- 8-KCurrent report: shareholder vote results
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
Questions about ENGNW
When does the ENGNW warrant expire?
ENGNW expires on October 31, 2028.
What is the strike price of ENGNW?
$11.50 per share; each warrant converts into 1 share, so exercising one warrant costs $11.50.
Can enGene Therapeutics Inc. redeem the ENGNW warrants early?
Yes. The company can call them if the share price reaches $18.00 for the required period (usually 20 of 30 trading days).
How many ENGNW warrants are outstanding?
8.55M listed warrants, equal to 12.8% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow ENGNW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

